ZYME vs PLBL Comparison

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Polibeli Group Ltd is a holding company without any business operations. It provides digital supply chain services and distribution sales through subsidiaries in a number of countries around the globe. Currently, its business is mainly in Japan and Indonesia, while also having business operations in some international locations, including Hong Kong, Europe, and Others. The single reportable segment contains product revenues derived from world-wide goods trading, and service revenues that are ancillary to world-wide goods trading business.